Pathologic grade and tumor size are associated with recurrence-free survival in patients with duodenal neuroendocrine tumors.
Untch BR, Bonner KP, Roggin KK, Reidy-Lagunes D, Klimstra DS, Schattner MA, Fong Y, Allen PJ, D'Angelica MI, DeMatteo RP, Jarnagin WR, Kingham TP, Tang LH.
Untch BR, et al. Among authors: roggin kk.
J Gastrointest Surg. 2014 Mar;18(3):457-62; discussion 462-3. doi: 10.1007/s11605-014-2456-x. Epub 2014 Jan 22.
J Gastrointest Surg. 2014.
PMID: 24448999